• Flying Squid@lemmy.world
    link
    fedilink
    arrow-up
    3
    arrow-down
    2
    ·
    1 year ago

    No it isn’t. It’s due to training. You can’t just walk into a production facility and start making Zoloft. And there is absolutely no guarantee that you will get enough people trained to know how to make Zoloft to keep up with demand. Because that, in part, is based on people’s willingness to work in a Zoloft production facility.

    So unless you’re talking about forced labor, that is an example of supply not necessarily meeting demand.

    • rockSlayer@lemmy.world
      link
      fedilink
      arrow-up
      3
      arrow-down
      2
      ·
      1 year ago

      Zoloft is mass manufactured in vats that produce thousands of pills each. Unfortunately the pharmacists that created Zoloft for Pfizer probably didn’t see a lot of benefit from it. Zoloft saw supply chain issues in the pandemic because of “just in time” supply chain practices.

      I feel like you’re imagining boutique drugs in this conversation. Boutique drugs are made onsite, typically in small pharmacies that specialize in making that drug, and are made for extremely rare conditions. I think people would flock to the field to solve all sorts of conditions that effected them or someone close to them